Human cellular inflammation in the pathology of acute cerebral ischaemia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 74, Issue 11, 2003, Pages 1476-1484

  Price, C J S ^a   Warburton, E A ^a   Menan, D K ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CELL PROTEIN; CHEMOKINE;

BRAIN ISCHEMIA; CEREBROSPINAL FLUID CYTOLOGY; CEREBROVASCULAR ACCIDENT; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0242441474     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.11.1476     Document Type: Review

References (85)

1. Investigators EAST. Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 2001;57:1428-34.
2. Directory ST. ASTIN: acute stroke therapy by inhibition of neutrophils, 2003.www.strokecenter.org/trialsand www.corvas.com/press_releases.
3. Council MR. Neuroprotection in acute brain injury after trauma and stroke. Field Review, 1998.
4. del Zoppo G, Ginis I, Hallenbeck JM, et al. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 2000;10:95-112.
5. Barone FC, Feuerstein GZ. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 1999;19:819-34.
6. Stall G, Jander S, Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 1998;56:149-71.
7. Becker KJ. Inflammation and acute stroke. Curr Opin Neurol 1998;11:45-9.
8. Iadecola C, Alexander M. Cerebral ischaemia and inflammation. Curr Opin Neurol 2001;14:89-94.
9. Arvin B, Neville LF, Barone FC, et al. The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 1996;20:445-52.
10. Emsley HC, Tyrrell PJ. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 2002;22:1399-419.
11. Rothwell NJ, Luheshi GN. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 2000;23:618-25.
12. Feuerstein GZ, Wang X, Barone FC. The role of cytokines in the pathology of stroke and neurotrauma. Neuroimmunomodulation 1998;5:143-59.
13. Zaremba J. Contribution of tumor necrosis factor alpha to the pathogenesis of stroke. Folia Morphol (Warsz) 2000;59:137-43.
14. Feuerstein GZ, Wang X, Barone FC. Cytokines in brain ischemia - the role of TNA alpha. Cell Mol Neurobiol 1998;18:695-701.
15. Pantoni L, Sorti C, Inzitari D. Cytokines and cell adhesion molecules in cerebral ischemia: experimental boses and therapeutic perspectives. Arterioscler Thromb Vasc Biol 1998;18:503-13.
16. Frijns CJ, Kappelle LJ. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002;33:2115-22.
17. Menon DK, Summors AC. Neuroprotection (including hypothermia). Curr Opin Anaethesiol 1998;11:495-6.
18. Prentice RL, Szatrowski TP, Kato H, et al. Leukocyte counts and cerebrovascular disease. J Chron Dis 1982;35:703-14.
19. Noto D, Barbagallo CM, Cavera G, et al. Leukocyte count, diabetes mellitus and age are strong predictors of stroke in a rural population in southern Italy: an 8-year follow-up. Atherosclerosis 2001;157:225-31.
20. Xu YB, Zhu JS, Zhang GP. Activation and free radical formation of leukocytes in patients with acute ischemic stroke. Chung Hua Nei Ko Tsa Chih 1994;33:799-802.
21. Suzuki S, Kelley RE, Reyes-Iglesias Y, et al. Cerebrospinal fluid and peripheral white blood cell response to acute cerebral ischemia. South Med J 1995;88:819-24.
22. Grau AJ, Berger E, Sung KL, et al. Granulocyte adhesion, deformability, and superoxide formation in acute stroke. Stroke 1992;23:33-9.
23. Galante A, Pietroiusti A, Magrini A, et al. Serial determinations of leukocyte aggregation in patients with ischemic stroke. Int J Neurosci 1993;73:69-76.
24. Galante A, Silvestrini M, Stanzione P, et al. Leucocyte aggregation in acute cerebrovascular disease. Acta Neurol Scand 1992;86:446-9.
25. Chang RR, Chien NT, Chen CH, et al. Spontaneous activation of circulating granulocytes in patients with acute myocardial and cerebral diseases. Biorheology 1992;29:549-61.
26. Grau AJ, Graf T, Hacke W. Altered influence of polymorphonuclear leukocytes on coagulation in acute ischemic stroke. Thromb Res 1994;76:541-9.
27. Sornas R, Ostlund H, Muller R. Cerebrospinal fluid cytology after stroke. Arch Neurol 1972;26:489-501.
28. Chuaqui R, Tapia J. Histologic assessment of the age of recent brain infarcts in man. J Neuropathol Exp Neurol 1993;52:481-9.
29. Lindsberg PJ, Carpen O, Paetau A, et al. Endorhelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 1996;94:939-45.
30. Pozzilli C, Lenzi GL, Argentino C, et al. Imaging of leukocytic infiltration in human cerebral infarcts. Stroke 1985;16:251-5.
31. Wang PY, Kao CH, Mui MY, et al. Leukocyte infiltration in acute hemispheric ischemic stroke [see comments]. Stroke 1993;24:236-40.
32. Akopov SE, Simonian NA, Grigorian GS. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke 1996;27:1739-43.
33. Peters AM, Lavender JP. Imaging inflammation with radiolabelled white cells: 99Tcm-HMPAO or 111In? [editorial]. Nucl Med Commun 1991;12:923-5.
34. Wade DT. Measurement in neurological rehabilitation. Oxford: Oxford University Press, 1992:293.
35. Fujinuma K, Sakai F, Iizuka T, et al. In-111-labeled leukocyte brain SPECT imaging in acute ischemic stroke in man. Rinsho Shinkeigaku 1997;37:13-20.
36. Syapin PJ, Skolnick P. Characterization of benzodiazepine binding sites in cultured cells of neural origin. J Neurochem 1979;32:1047-51.
37. Benavides J, Cornu P, Dennis T, et al. Imaging of human brain lesions with an omega 3 site radioligand. Ann Neurol 1988;24:708-12.
38. Canat X, Carayon P, Bouaboula M, et al. Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sci 1993;52:107-18.
39. Sette G, Baron JC, Young AR, et al. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke 1993;24:2046-57; discussion 2057-8.
40. 3H]PK11195 binding to activated microglia. J Neurocytol 1997;26:77-82.
41. Raghavendra Rao VL, Dogan A, Bowen KK, et al. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp Neurol 2000;161:102-14.
42. Rao VL, Bowen KK, Rao AM, et al. Up-regulation of the peripheral-type benzadiazepine receptor expression and [(3)H]PK11195 binding in gerbil hippocampus after transient forebrain ischemia. J Neurosci Res 2001;64:493-500.
43. Junck L, Jewett D, Kilbourn M. PET imaging of cerebral infarcts using a ligand for peripheral benzodiazepine-biding site. Neurology 1990;40:265.
44. Ramsay SC, Weiller C, Myers R, et al. Monitoring by PET of macrophage accumulation in brain after ischaemic stroke [letter]. Lancet 1992;339:1054-5.
45. 11C]PK11195 and positron emission tomography in patients after ischemic stroke [In Process citation]. Neuroreport 2000;11:2957-60.
46. Stephenson DT, Schober DA, Smalstig EB, et al. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J Neurosci 1995;15:5263-74.
47. Zhang W, Smith C, Shapiro A, et al. Increased expression of bioactive chemokines in human cerebromicrovascular endothelial cells and astrocytes subjected to simulated ischemia in vitro. J Neuroimmunol 1999;101:148-60.
48. Sekido N, Mukaida N, Harada A, et al. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 1993;365:654-7.
49. Mukaida N, Matsumoto T, Yokoi K, et al. Inhibition of neutrophil-mediated acute inflammation injury by an antibody against interleukin-8 (IL-8). Inflamm Res 1998;47(suppl 3):S151-7.
50. Gerszten RE, Garcia-Zepeda EA, Lim YC, et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999;398:718-23.
51. Wang X, Yue TL, Barone FC, et al. Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke 1995;26:661-5; discussion 665-6.
52. Che X, Ye W, Panga L, et al. Monocyte chemoattroctant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res 2001;902:171-7.
53. Takami S, Nishikawa H, Minami M, et al. Induction of macrophage inflammatory protein MIP-1alpha mRNA on glial cells after focal cerebral ischemia in the rat. Neurosci Lett 1997;227:173-6.
54. Smith WB, Gamble JR, Clark-Lewis I, et al. Interleukin-8 induces neutrophil transendothelial migration. Immunology 1991;72:65-72.
55. Kostulas N, Kivisakk P, Huang Y, et al. Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA. Stroke 1998;29:462-6.
56. Tarkowski E, Rosengren L, Blomstrand C, et al. Intrathecal release of pro-and anti-inflammatory cytokines during stroke. Clin Exp Immunol 1997;110:492-9.
57. Nandate K, Vuylsteke A, Crosbie AE, et al. Cerebrovascular cytokine responses during coronary artery bypass surgery: specific production of interleukin-8 and its attenuation by hypothermic cardiopulmonary bypass. Anesth Analg 1999;89:823-8.
58. Losy J, Zaremba J. Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke 2001;32:2695-6.
59. Biber K, Zuurman MW, Dijkstra IM, et al. Chemokines in the brain: neuroimmunology and beyond. Curr Opin Pharmacol 2002;2:63-8.
60. Kostulas N, Pelidou SH, Kivisakk P, et al. Increased IL-1 beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 1999;30:2174-9.
61. Detmers PA, Lo SK, Olsen-Egbert E, et al. Neutrophil-activating protein 1/ interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 1990;171:1155-62.
62. Whalen MJ, Carlos TM, Kochanek PM, et al. Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Crit Care Med 2000;28:929-34.
63. Gaetani P, Tartara F, Pignatti P, et al. Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 1998;20:337-42.
64. Iadecola C, Ross ME. Molecular pathology of cerebral ischemia: delayed gene expression and strategies for neuroprotection. Ann NY Acad Sci 1997;835:203-17.
65. D'Ambrosio AL, Pinsky DJ, Connolly ES. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection. Mol Med 2001;7:367-82.
66. Hess DC, Bhutwala T, Sheppard JC, et al. ICAM-1 expression on human brain microvascular endothelial cells. Neurosci Lett 1994;168:201-4.
67. Clark WM, Coull BM, Briley DP, et al. Circulating intercellular adhesion molecule-1 levels and neutrophil adhesion in stroke. J Neuroimmunol 1993;44:123-5.
68. Kim JS, Chopp M, Chen H, et al. Adhesive glycoproteins CD11a and CD18 are upregulated in the leukocytes from patients with ischemic stroke and transient ischemic attacks. J Neurol Sci 1995;128:45-50.
69. Frijns CJ, Kappelle LJ, van Gijn J, et al. Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 1997;28:2214-18.
70. Fiszer U, Korczak-Kowalska G, Palasik W, et al. Increased expression of adhesion molecule CD18 (LFA-1beta) on the leukocytes of peripheral blood in patients with acute ischemic stroke. Acta Neurol Scand 1998;97:221-4.
71. Fassbender K, Mossner R, Motsch L, et al. Circulating selectin-and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke 1995;26:1361-4.
72. Shyu KG, Chang H, Lin CC. Serum levels of intercellular adhesion molecule-1 and E-selectin in patients with acute ischaemic stroke. J Neurol 1997;244:90-3.
73. Stanimirovic DB, Wong J, Shapiro A, et al. Increase in surface expression of ICAM-1, VCAM-1 and E-selectin in human cerebromicrovascular endothelial cells subjected to ischemia-like insults. Acta Neurochir Suppl 1997;70:12-16.
74. Bitsch A, Klene W, Murtada L, et al. A longitudinal prospective study af soluble adhesion molecules in acute stroke. Stroke 1998;29:2129-35.
75. Kaluza J, Krupinski J, Kumar P, et al. VCAM-1 expression on reactive and tumour astrocytes. Folia Histochem Cytobiol 1994;32:17-20.
76. Gelati M, Corsini E, De Rossi M, et al. Methylprednisolone acts on peripheral blood mononuclear cells and endothelium in inhibiting migration phenomena in patients with multiple sclerosis. Arch Neurol 2002;59:774-80.
77. Oudeqa M, Vargas CG, Weber AB, et al. Long-term effects of methylprednisolone following transection of adult rat spinal cord. Eur J Neurosci 1999;11:2453-64.
78. Slivka AP, Murphy EJ. High-dose methylprednisolone treatment in experimental focal cerebral ischemia. Exp Neurol 2001;167:166-72.
79. Kim JS, Chopp M, Gautam SC. High dose methylprednisolone therapy reduces expression of JE/MCP-1 mRNA and macrophage accumulation in the ischemic rat brain. J Neurol Sci 1995;128:28-35.
80. Qizilbash N, Lewington SL, Lopez-Arrieta JM. Carticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev 2000:2.
81. Vuorte J, Lindsberg PJ, Kaste M, et al. Anti-ICAM-1 monoclonal antibody R6.5 Enlimomab) promotes activation of neutrophils in whole blood. J Immunol 1999;162:2353-7.
82. 18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-11.
83. Maini RN, Taylor PC. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med 2000;51:207-29.
84. Frenette PS. Locking a leukocyte integrin with statins. N Engl J Med 2001;345:1419-21.
85. Group NSPR. Report, 2002. http://www.ninds.nih.gov/about_ninds/ 04_2002_Stroke_PRG_Report.htm